Reportify - AI 投资研究深度内容问答引擎 (2024)

DoorDash: 5 Compelling Reasons to Buy the Dip

Key Points With a 65% market share, DoorDash is the nation's largest food delivery service. DoorDash’s network includes over 550,000 partner restaurants and retailers, and over 32 million consumer customers. DoorDash charges restaurants a commission of up to 30% and also collects delivery and service fees from customers, with take rates exceeding 12%. 5 stocks we like better than DoorDash ...

Reportify - AI 投资研究深度内容问答引擎 (1)

DoorDash(DASH) MarketBeat·

2024-04-29 11:01

Reportify - AI 投资研究深度内容问答引擎 (2)

Reportify - AI 投资研究深度内容问答引擎 (3)

Best Income Stocks to Buy for April 29th

Here are two stocks with buy rank and strong income characteristics for investors to consider today, April 29: The Bank of N.T. Butterfield & Son Limited (NTB) : This commercial bank has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.8% the last 60 days. This Zacks Rank #1 company has a dividend yield of 5.2%, compared with the industry average of 4.3%. Preferred Bank (PFBC) : This company which provides commercial banking products and services has witnessed the Zacks Cons ...

Reportify - AI 投资研究深度内容问答引擎 (4)

Zacks Investment Research·

2024-04-29 11:01

EYLEA® HD (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Sustained and Clinically Meaningful Outcomes in Serious Retinal Diseases

TARRYTOWN, N.Y., April 29, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced the presentation of positive long-term results and subgroup analyses from the pivotal clinical program of EYLEA® HD (aflibercept) Injection 8 mg. The presentations are part of 14 accepted abstracts on EYLEA HD and EYLEA® (aflibercept) Injection 2 mg that will be shared at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting from May 5 to 9 in Seattle. "Our extensive dat ...

Reportify - AI 投资研究深度内容问答引擎 (7)

Regeneron(REGN) Newsfilter·

2024-04-29 11:00

ECARX to Report First Quarter 2024 Financial Results on May 20, 2024

SHANGHAI, China, April 29, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings, Inc. (NASDAQ:ECX) ("ECARX"), a global mobility tech provider, today announced that it will report its financial results for the first quarter of 2024 before the U.S. market opens on Monday, May 20, 2024. Company management will hold an earnings conference call via live audio webcast to discuss the financial results and will be available to answer questions from analysts and institutional investors. Earnings Conference Call & Webcast Details ...

Reportify - AI 投资研究深度内容问答引擎 (8)

ECARX(ECX) Newsfilter·

2024-04-29 11:00

Canadian Solar Wins Green Project Bond of the Year Award by Environmental Finance

GUELPH, ON, April 29, 2024 /PRNewswire/ -- Canadian Solar Inc. (the "Company", or "Canadian Solar") (NASDAQ: CSIQ) today announced that it has won Environmental Finance's Green Project Bond of the Year award for its JPY 18.5 billion green samurai private placement. Canadian Solar completed its three-year, JPY 18.5 billion ($120 million) private placement in 2023. The innovative bond enhances liquidity and flexibility, empowering Canadian Solar's global development business, Recurrent Energy, to grow its sol ...

Reportify - AI 投资研究深度内容问答引擎 (9)

Solar(CSIQ) Prnewswire·

2024-04-29 11:00

JinkoSolar Repurchased 4,203,178 ADSs under Its Share Repurchase Program

SHANGRAO, China, April 29, 2024 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that as of the date of this press release, the Company has repurchased a total of 4,203,178 ADSs in an aggregate amount of approximately US$104.1 million in the open market under its share repurchase program announced in July 2022 and the extended share repurchase program announced in December ...

Reportify - AI 投资研究深度内容问答引擎 (10)

JinkoSolar(JKS) Prnewswire·

2024-04-29 10:47

Operating hashrate increased to 9 EH/s

SYDNEY, Australia, April 29, 2024 (GLOBE NEWSWIRE) -- IREN (Iris Energy Limited) (NASDAQ:IREN) (together with its subsidiaries, "IREN" or "the Company"), a leading next-generation data center business powering the future of Bitcoin, AI and beyond, today provided a business update. IREN is pleased to announce that its expansion is ahead of schedule and operating hashrate has increased to 9 EH/s. The Company now also expects to achieve 10 EH/s in May 2024. IREN's fully funded expansion to 20 EH/s in 2024 rema ...

Reportify - AI 投资研究深度内容问答引擎 (11)

Iris Energy (IREN) Newsfilter·

2024-04-29 10:45

Could Microsoft Stock Help You Become a Millionaire?

The company smashed quarterly earnings and is potentially on a path to dominate AI.Microsoft (MSFT 1.82%) captivated Wall Street for several quarters now, with its stock up 41% over the last 12 months. While some of its peers suffered from macroeconomic headwinds, the Windows company reported solid growth and continued to beat analysts' expectations. Meanwhile, Microsoft rallied investors with an expanding position in artificial intelligence (AI).In fact, Microsoft overtook Apple as the world's most valuab ...

Reportify - AI 投资研究深度内容问答引擎 (12)

Microsoft(MSFT) The Motley Fool·

2024-04-29 10:45

Reportify - AI 投资研究深度内容问答引擎 (13)

Reportify - AI 投资研究深度内容问答引擎 (14)

Gravitas Worldwide Streamlines Customs Clearance Using Descartes e-Customs™ Solution

LONDON and ATLANTA, April 29, 2024 (GLOBE NEWSWIRE) -- Descartes Systems Group (NASDAQ:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that global freight broker Gravitas Worldwide is more efficiently managing customs declarations for aerospace clients by using Descartes e-Customs™ to automate traditionally manual customs processes. "We ship anything from aircraft engines to rivets for our clients. Since many shipments take place overnight, it is critical ...

Reportify - AI 投资研究深度内容问答引擎 (15)

Descartes(DSGX) Newsfilter·

2024-04-29 10:45

Ocugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024

MALVERN, Pa., April 29, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ:OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Benjamin Bakall, MD, PhD, Director of Clinical Research at Associated Retina Consultants and Clinical Assistant Professor at the University of Arizona, College of Medicine—Phoenix will present data from the OCU400 Phase 1/2 clinical trial at the Retinal Cell and Gen ...

Reportify - AI 投资研究深度内容问答引擎 (16)

Ocugen(OCGN) Newsfilter·

2024-04-29 10:45

Reportify - AI 投资研究深度内容问答引擎 (2024)
Top Articles
Latest Posts
Article information

Author: Arline Emard IV

Last Updated:

Views: 6228

Rating: 4.1 / 5 (52 voted)

Reviews: 91% of readers found this page helpful

Author information

Name: Arline Emard IV

Birthday: 1996-07-10

Address: 8912 Hintz Shore, West Louie, AZ 69363-0747

Phone: +13454700762376

Job: Administration Technician

Hobby: Paintball, Horseback riding, Cycling, Running, Macrame, Playing musical instruments, Soapmaking

Introduction: My name is Arline Emard IV, I am a cheerful, gorgeous, colorful, joyous, excited, super, inquisitive person who loves writing and wants to share my knowledge and understanding with you.